The model performance was also evaluated via ROC analysis (Figure 3j), achieving an AUC of 0.932 (95% CI, 0.876–0.961) for pRCC, 0.926 (95% CI, 0.874–0.965) for chRCC, and 0.925 (95% CI, 0.882–0.947) for ccRCC. This evidence concerns the gene PRCC and nonpapillary renal cell carcinoma.